1.A prototype 3D printed suction port adapter for a wireless otoendoscope
Ma. Cristina Z. Garcia ; Jay Pee M. Amable
Philippine Journal of Otolaryngology Head and Neck Surgery 2024;39(1):44-48
Background and Objective:
To design and fabricate a suction port adapter to use various sizes of suction cannulas
with a wireless otoendoscope enabling ear cleaning under endoscopic guidance demonstrated using an ear examination simulator.
Methods:
Design: Instrument Innovation. Setting: Tertiary Private Training Hospital. Patient: Ear Examination Simulator.
Results:
The fabricated suction port adapters were able to hold the wireless otoendoscope and suction cannulas together, allowing simultaneous inspection of the ear canal and suctioning of ear canal debris using the Ear Examination Simulator.
Conclusion
Our prototype 3D-printed suction port adapters for a wireless otoendoscope may improve ear cleaning by enhancing the accuracy of suctioning debris and decreasing duration since they hold the suction cannulas in place under endoscopic guidance. They may aid ENT physicians in easier visualization and simultaneous ear cleaning of patients and improve ear cleaning techniques and times, especially among less experienced physicians, but actual clinical trials are needed to confirm this.
Printing, Three-Dimensional
;
Cerumen
;
Otoscopy
2.Effectiveness of immature Mangifera indica Linn (mango) fruit in reducing the Ascaris lumbricoides infection among children: a non-inferiority randomized controlled trial.
Arianna Julia S. Enriquez ; Grachella Jana Beatriz M. Erlano ; John Ruben A. Esperanza ; Michael Kevin H. Espino ; Jan Paola B. Frayna ; Anne Christine E. Gagui ; Gerald M. Gaitos ; Raquelynne M. Galicia ; Joseph R. Gallardo ; James Rainier M. Garcia ; Ma. Cristina Z. Garcia ; Jose Ronilo G. Juangco
Health Sciences Journal 2018;7(2):73-79
INTRODUCTION:
This study aimed to compare the effectiveness of immature Magnifera indica L. (mango) fruit with albendazole in reducing Ascaris lumbricoides infection among children.
METHODS:
Children aged 2 to 14 years were enrolled in a randomized, controlled, non-inferiority trial. Participants were randomly allocated to receive 250 mL immature mango fruit puree daily for 3 days or one dose of albendazole 400 mg tablet. Egg reduction rates and cure rates were computed and compared. Adverse effects were monitored during and after administration of treatment.
RESULTS:
There was a statistically significant decrease between the pre- and post-treatment EPG of those who took immature mango fruit (p < 0.001) and those who took albendazole (p < 0.001). There was a higher ERR and CR for the albendazole group, but the difference was not significant (p = 0.472, p = 785, respectively). Risk analysis of reduction in intensity showed mango is non-inferior to albendazole (RR = 0.80, 95% CI 0.67, 0.97; p = 0.026). Risk analysis of cure showed mango is noninferior to albendazole in both PP (RR = 0.92, 95% CI 0.68, 1.25; p = 0.607) and ITT (RR=0.79, 95% CI 0.58, 1.08; p = 0.139).
CONCLUSION
Immature Mangifera indica Linn is non-inferior to albendazole in terms of effectiveness in the reduction of ascariasis infection.
Ascariasis